press release investor nutraceuticals video science eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 months Jul 22, 2025 4:04:00 PM
press release investor nutraceuticals medicine science eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturing Jun 26, 2025 4:04:00 PM
investor press clippings video Slack Capital interview: Chris Marlett, Chairman of the Board May 22, 2025 5:23:00 PM
heltzen press release investor press clippings Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything' May 16, 2025 9:09:00 AM
investor press clippings video Slack Capital interview: Tyler Korman, VP of Research May 15, 2025 4:24:00 PM
heltzen investor press clippings video Slack Capital: EXOZ investment report and CEO interview May 13, 2025 5:30:00 PM
press release investor eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST today May 12, 2025 4:04:00 PM
press release investor eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM EST May 7, 2025 4:58:15 PM
.jpg?width=1024&height=1024&name=Paul+NCT(HD).jpg)
.png?width=1024&height=1024&name=ExoZymes%20-%20MDB%20Capital%20(1).png)
.png?width=1024&height=1024&name=_ExoZymes%20-%20Commercial%20(1).png)
.png?width=1024&height=1024&name=ExoZymes%20-%20Science%20(1).png)
.png?width=1024&height=1024&name=ExoZymes%20-%20Introduction%20(1).png)
